Pennsylvania experienced a slight loss in manufacturing jobs over the past 12 months, according to the new Pennsylvania Manufacturers Register, an industrial guide published annually by Manufacturers' News Inc. of Evanston, Ill. MNI reports Pennsylvania lost 7,332 industrial jobs (less than 1 percent) since July 2005, a moderate loss compared to the 2 percent loss MNI reported in the 12 months prior.
"Hopefully this indicates a slowing, if not a reversal, of the loss of Pennsylvania manufacturing jobs," said Tom Dubin, president of MNI. "Many of the industrial jobs that could be shipped overseas have already moved."
According to Manufacturers' News, Pennsylvania is now home to 19,727 manufacturing companies employing 930,921 workers, ranking it fifth in the nation by number of plants and jobs. Pennsylvania accounts for 30 percent of the mid- Atlantic region's manufacturing jobs and 29 percent of its plants. MNI's survey profiles both large and small Pennsylvania manufacturers, including startup companies with just a few employees.
Philadelphia remains Pennsylvania's industrial leader with 1,220 companies and 59,616 jobs, according to the register. Pittsburgh accounts for 954 companies and 40,351 jobs, while Erie is home to 406 manufacturers and 25,476 jobs. MNI reports all three cities gained plants over the past 12 months.
The state's largest sector by employment is plastic products, representing 41,697 jobs. Commercial printing follows with 29,882 jobs while pharmaceutical preparations account for 23,797 jobs.
Tuesday, August 01, 2006
Gene Logic to Cut 80 Jobs
GAITHERSBURG, Md. (AP) - Gene Logic Inc., which provides genetic testing services to drug makers, on Tuesday said it will cut about 80 jobs in the restructuring of its genomics division.
The company said the restructuring will result in about $1.5 million in severance and outplacement costs, but will save about more than $8 million per year.
Employees supporting existing products and services for customers will be maintained. The company's preclinical and drug repositioning divisions will not be affected.
The company withdrew its guidance for 2006 and 2007 in June, and announced it would perform a review of its genomics division.
Gene Logic shares rose 4 cents, or 3.3 percent, to close at $1.27 on the Nasdaq.
© 2006 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
The company said the restructuring will result in about $1.5 million in severance and outplacement costs, but will save about more than $8 million per year.
Employees supporting existing products and services for customers will be maintained. The company's preclinical and drug repositioning divisions will not be affected.
The company withdrew its guidance for 2006 and 2007 in June, and announced it would perform a review of its genomics division.
Gene Logic shares rose 4 cents, or 3.3 percent, to close at $1.27 on the Nasdaq.
© 2006 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Subscribe to:
Posts (Atom)
